Chemokine Stromal Cell–derived Factor 1α Activates Basophils by Means of CXCR4

JQ Tan,HH Jacobi,C Jing,CM Reimert,S Quan,S Dissing,LK Poulsen,PS Skov
DOI: https://doi.org/10.1067/mai.2000.108108
IF: 14.29
2000-01-01
Journal of Allergy and Clinical Immunology
Abstract:Background: The CXC chemokine receptor 4 (CXCR4) is predominantly expressed on inactivated naive T lymphocytes, B lymphocytes, dendritic cells, and endothelial cells. CXC chemokine stromal cell–derived factor 1α (SDF-1α) is the only known ligand for CXCR4. To date, the CXCR4 expression and function of SDF-1α in basophils are unknown. Objective: The purpose of this study was to investigate the expression of CXCR4 and functions of SDF-1α in basophils and to characterize the role of the CXCR4-SDF-1α receptor ligand pair in the allergic inflammation. Methods: Basophil purification, flow cytometry, real-time quantitative RT-PCR assay, Northern blotting, intracellular free Ca2+ change, chemotaxis assay, and histamine release assay were used. Results: CXCR4 is abundantly expressed on peripheral blood resting basophils (91%). Likewise, CXCR4 messenger (m)RNA is expressed in resting basophils (3.2 × 103 copies per 2 × 102 cells). The existence of CXCR4 mRNA was also confirmed in basophils by means of Northern blot analysis. SDF-1α induces an increase in intracellular free Ca2+ in basophils. SDF-1α activates basophils to chemotaxis (chemotactic index = 3.8) and histamine release (36% of total content) through CXCR4 on the cells. The chemokines SDF-1α, eotaxin, RANTES, monocyte chemoattractant protein (MCP) 1, and macrophage inflammatory protein (MIP) 1α have been demonstrated at different potencies in induction of chemotaxis (eotaxin > SDF-1α > RANTES ≅ MCP-1 >> MIP-1α) and histamine release (MCP-1 ≅ SDF-1α > eotaxin > RANTES > MIP-1α). The optimal concentration seen for SDF-1α effects (chemotaxis and histamine release) on basophils was 100 ng/mL. Conclusion: These results indicate that the CXCR4-SDF-1α receptor ligand pair may be important for the recruitment and activation of the basophils, which is a characteristic effector cell of the allergic inflammation. (J Allergy Clin Immunol 2000;106:313-20.)
What problem does this paper attempt to address?